Pay in 4 interest-free payments of $5.93 Learn more
Ships within 48 hours · Estimated delivery Oct 20 - Oct 25
Overview of GLP-1 Receptor Agonists The major GLP-1 receptor agonists available on the market currently are: Dulaglutide (Trulicity) Exenatide extended release (Bydureon BCise) Exenatide (Byetta) Semaglutide (Ozempic, Rybelsus) Liraglutide (Victoza, Saxenda) Lixisenatide (Adlyxin) What is Dulaglutide (Trulicity) and its mechanism of action Dulaglutide, sold as Trulicity, is an injectable GLP-1 receptor agonist medication designed for the treatment of type 2 diabetes
Anti-cancer and protective gene data The gene analysis also revealed that GHK-Cu downregulates 70% of cancer-related genes examined, including metastatic pathways, while upregulating DNA repair and caspase (programmed cell death) genes that eliminate damaged cells
Low oxygen delivery can slow down metabolic functions, making it harder for your body to burn calories
Friedenreich CM, Pialoux V, Wang Q, Shaw E, Brenner DR, Waltz X et al (2016) Effects of exercise on markers of oxidative stress: an ancillary analysis of The Alberta physical activity and breast cancer prevention trial
GHK-Cu in the morning or one night, retinoids or Vitamin C on alternate evenings
US$ 29.76
US$ 28.83
US$ 27.42
US$ 27.84
